---
figid: PMC4432002__3049f2
figtitle: Role of the BM niche in MM pathogenesis
organisms:
- NA
pmcid: PMC4432002
filename: 3049f2.jpg
figlink: /pmc/articles/PMC4432002/figure/F2/
number: F2
caption: Role of the BM niche in MM pathogenesis. The blue oval in the center is the
  MMC, with its close interplay with cellular and acellular components of the BM.
  The pale orange ovals represent relevant cytokines/chemokines in the BM milieu.
  Dotted arrows indicate differentiation, whereas solid arrows indicate secretion
  and/or effect on a target cell. Yellow squares contain a synopsis of the overall
  effect of cytokines and cell-to-cell contact on the target cell. Key signaling cascades,
  transmembrane proteins, and intracellular organelles, which are of interest for
  molecularly targeted therapies, are represented. BMSC, BM stromal cell; CAF, cancer-associated
  fibroblast; CCL2, chemokine (C-C motif) ligand 2; CTLA4, cytotoxic T-lymphocyte-associated
  protein 4; CXCL12, chemokine (C-X-C motif) ligand 12; CXCR4, chemokine (C-X-C motif)
  receptor 4; DKK-1, dickkopf WNT signaling pathway inhibitor 1; ER, endoplasmic reticulum;
  FN, fibronectin; HGF, hepatocyte growth factor; HIF-1α, hypoxia-inducible factor
  1α; ICAM1, intercellular adhesion molecule 1; IGF-1, insulinlike growth factor 1;
  ITGB1, integrin β1; ITGB2, integrin β2; JNK, c-JUN N-terminal kinase; MAPK1, mitogen-activated
  protein kinase 1; MDSC, myeloid-derived suppressor cell; MIP-1α, macrophage inflammatory
  protein 1α; MUC-1, mucin 1; NK-T cells, natural killer T cells; OPG, osteoprotegerin;
  PD-1, programmed cell death 1; PD-L1, programmed ligand death 1; RANK, receptor
  activator of NF-κB; RANKL, RANK ligand; RBC, red blood cell; TGF-β, transforming
  growth factor β; TH17, T helper 17 cell; Treg, regulatory T cell; VCAM1, vascular
  cell adhesion molecule 1; VEGFA, vascular endothelial growth factor A; WNT, wingless-type.
  Adapted from Bianchi and Anderson with permission.
papertitle: Pathogenesis beyond the cancer clone(s) in multiple myeloma.
reftext: Giada Bianchi, et al. Blood. 2015 May 14;125(20):3049-3058.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8863778
figid_alias: PMC4432002__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4432002__F2
ndex: 6044e0c6-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4432002__3049f2.html
  '@type': Dataset
  description: Role of the BM niche in MM pathogenesis. The blue oval in the center
    is the MMC, with its close interplay with cellular and acellular components of
    the BM. The pale orange ovals represent relevant cytokines/chemokines in the BM
    milieu. Dotted arrows indicate differentiation, whereas solid arrows indicate
    secretion and/or effect on a target cell. Yellow squares contain a synopsis of
    the overall effect of cytokines and cell-to-cell contact on the target cell. Key
    signaling cascades, transmembrane proteins, and intracellular organelles, which
    are of interest for molecularly targeted therapies, are represented. BMSC, BM
    stromal cell; CAF, cancer-associated fibroblast; CCL2, chemokine (C-C motif) ligand
    2; CTLA4, cytotoxic T-lymphocyte-associated protein 4; CXCL12, chemokine (C-X-C
    motif) ligand 12; CXCR4, chemokine (C-X-C motif) receptor 4; DKK-1, dickkopf WNT
    signaling pathway inhibitor 1; ER, endoplasmic reticulum; FN, fibronectin; HGF,
    hepatocyte growth factor; HIF-1α, hypoxia-inducible factor 1α; ICAM1, intercellular
    adhesion molecule 1; IGF-1, insulinlike growth factor 1; ITGB1, integrin β1; ITGB2,
    integrin β2; JNK, c-JUN N-terminal kinase; MAPK1, mitogen-activated protein kinase
    1; MDSC, myeloid-derived suppressor cell; MIP-1α, macrophage inflammatory protein
    1α; MUC-1, mucin 1; NK-T cells, natural killer T cells; OPG, osteoprotegerin;
    PD-1, programmed cell death 1; PD-L1, programmed ligand death 1; RANK, receptor
    activator of NF-κB; RANKL, RANK ligand; RBC, red blood cell; TGF-β, transforming
    growth factor β; TH17, T helper 17 cell; Treg, regulatory T cell; VCAM1, vascular
    cell adhesion molecule 1; VEGFA, vascular endothelial growth factor A; WNT, wingless-type.
    Adapted from Bianchi and Anderson with permission.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFA
  - SDC1
  - IL17A
  - IL4
  - TNFRSF11A
  - CCL2
  - TNFSF11
  - BTF3P11
  - TNFRSF11B
  - TNF
  - RN7SL263P
  - RPL17
  - TPGS2
  - IGKV2D-14
  - IL6
  - BPI
  - H3P21
  - POLI
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - BTG3
  - CBLIF
  - AKT1
  - AKT2
  - AKT3
  - KAT2B
  - CXCL12
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - Cancer
---
